Non-medication | Oral medication alone | LAI medication | |||
---|---|---|---|---|---|
Overall | |||||
Observational period (person-years) | 80,104 | 169,948 | 5612 | ||
Outcome event (count) | 36,721 | 63,390 | 1478 | ||
1 episode | |||||
Observational period | 61,884 | 114,631 | 2895 | ||
Outcome event | 22,593 | 32,045 | 601 | ||
2 episode | |||||
Observational period | 11,992 | 33,385 | 1476 | ||
Outcome event | 7187 | 13,999 | 401 | ||
3 episode | |||||
Observational period | 3476 | 12,042 | 635 | ||
Outcome event | 3124 | 7098 | 213 | ||
4 or more episode | |||||
Observational period | 2752 | 9889 | 606 | ||
Outcome event | 3817 | 10,248 | 263 | ||
IR | |||||
Overall | 4.58 (4.47–4.70) | 3.73 (3.67–3.79) | 2.63 (2.39–2.91) | ||
1 episode without SGA before | 2.68 (2.55–2.81) | 2.21 (2.10–2.32) | 1.57 (1.01–2.47) | ||
1 episode with SGA before | 4.28 (4.13–4.43) | 2.94 (2.87–3.01) | 2.15 (1.85–2.50) | ||
2 episode | 5.99 (5.64–6.38) | 4.19 (4.04–4.36) | 2.71 (2.24–3.29) | ||
3 episode | 8.98 (8.03–10.06) | 5.90 (5.55–6.27) | 3.33 (2.51–4.47) | ||
4 or more episode | 13.88 (12.28–15.74) | 10.36 (9.71–11.07) | 4.31 (3.25–5.79) | ||
Only oral medication IR/non-medication IR | LAI IR/non-medication IR | ||||
Overall | Reference | 0.81 (0.80–0.83) | < 0.001 | 0.57 (0.52–0.63) | < 0.001 |
1 episode | Reference | 0.77 (0.75–0.78) | < 0.001 | 0.57 (0.49–0.66) | < 0.001 |
2 episode | Reference | 0.70 (0.67–0.73) | < 0.001 | 0.45 (0.37–0.55) | < 0.001 |
3 episode | Reference | 0.66 (0.62–0.70) | < 0.001 | 0.37 (0.28–0.50) | < 0.001 |
4 or more episode | Reference | 0.75 (0.70–0.80) | < 0.001 | 0.31 (0.23–0.42) | < 0.001 |
LAI IR/only oral medication IR | |||||
Overall | Reference | 0.71 (0.64–0.78) | < 0.001 | ||
1 episode | Reference | 0.74 (0.65–0.86) | < 0.001 | ||
2 episode | Reference | 0.65 (0.53–0.79) | < 0.001 | ||
3 episode | Reference | 0.56 (0.43–0.76) | < 0.001 | ||
4 or more episode | Reference | 0.42 (0.31–0.56) | < 0.001 |